Biopsy Forceps Polypectomy Snares and EUS Needles

Biopsy Forceps Polypectomy Snares and EUS Needles Market Outlook

The global market for Biopsy Forceps, Polypectomy Snares, and EUS Needles is projected to reach approximately USD 1.6 billion by 2033, exhibiting a compound annual growth rate (CAGR) of around 7.5% from 2025 to 2033. The increasing prevalence of gastrointestinal diseases, coupled with the growing demand for minimally invasive surgical procedures, is driving the market's expansion. Additionally, advancements in endoscopic techniques and the rising awareness regarding the early diagnosis of cancers contribute significantly to the market growth. The ongoing technological innovations and the introduction of advanced biopsy instruments are further anticipated to bolster the industry landscape. Furthermore, a surge in the geriatric population, which is more susceptible to various health conditions, is expected to play a pivotal role in augmenting the demand for biopsy and polypectomy products.

Growth Factor of the Market

Several factors are contributing to the growth of the Biopsy Forceps, Polypectomy Snares, and EUS Needles market. Firstly, the increasing incidence of cancer and gastrointestinal disorders is prompting a higher demand for diagnostic and therapeutic procedures, resulting in an uptick in the utilization of biopsy forceps and related products. Secondly, the healthcare sector is witnessing a significant shift towards minimally invasive techniques, which are associated with shorter recovery times and reduced postoperative complications, thus, enhancing patient outcomes. Thirdly, government initiatives to improve healthcare infrastructure, especially in emerging economies, are facilitating greater access to advanced diagnostic tools, including biopsy forceps and polypectomy snares. Additionally, technological advancements, including the development of specialized biopsy instruments for various clinical applications, are expected to further stimulate market growth. Lastly, ongoing research studies focusing on improving biopsy techniques are likely to yield innovative products that will cater to specific medical needs, thus, driving the market forward.

Key Highlights of the Market

• The market is expected to showcase robust growth due to increasing cancer prevalence.
• Technological innovations are leading to the development of advanced biopsy instruments.
• The shift towards minimally invasive procedures is a significant growth driver.
• Government initiatives are improving access to healthcare services globally.
• The rising geriatric population necessitates enhanced diagnostic tools.

By Product Type

Reusable Biopsy Forceps:

Reusable biopsy forceps are designed for multiple uses, making them a cost-effective option for healthcare providers. These instruments are typically made from durable materials that can withstand sterilization processes, allowing them to maintain their functionality over numerous procedures. The growing preference for eco-friendly and sustainable medical instruments has led to an increased demand for reusable biopsy forceps. Additionally, hospitals and surgical centers are investing in these tools due to their long-term cost savings, as well as their reliability in delivering high-quality biopsy samples. The continuous advancements in manufacturing techniques have improved the efficiency and precision of reusable biopsy forceps, further bolstering their adoption in clinical settings.

Disposable Biopsy Forceps:

Disposable biopsy forceps are gaining traction in the healthcare sector due to their convenience and reduced risk of cross-contamination. These instruments are designed for single-use, eliminating the need for complex cleaning and sterilization processes. As healthcare facilities place a greater emphasis on patient safety and infection control, disposable biopsy forceps are becoming the preferred choice for many endoscopists. The growth in minimally invasive procedures is also driving the demand for disposable tools, as they provide a sterile option for each patient, thereby enhancing overall procedural efficiency. Furthermore, technological advancements in the design of disposable biopsy forceps are leading to improved sampling capabilities, which is expected to further boost their market presence.

Hot Biopsy Forceps:

Hot biopsy forceps are specialized instruments that utilize heat to coagulate tissue as they obtain samples, allowing for simultaneous resection and biopsy. This dual functionality makes them particularly advantageous in procedures where there is a risk of bleeding. The rising prevalence of conditions requiring thermal ablation techniques, such as certain types of cancers, is driving the demand for hot biopsy forceps. Additionally, the increasing adoption of endoscopic mucosal resection and submucosal dissection procedures further emphasizes the need for hot forceps. The ability of these instruments to provide precise tissue sampling while minimizing damage to surrounding tissues is enhancing their acceptance among healthcare professionals, thereby contributing to market growth.

By Application

Hospitals:

Hospitals are the primary end-users of biopsy forceps, polypectomy snares, and EUS needles, as they offer comprehensive medical services, including surgical and diagnostic procedures. The growing number of hospital admissions for gastrointestinal disorders and cancers is driving the demand for these instruments. Hospitals are increasingly adopting advanced biopsy techniques, leading to a heightened need for specialized equipment. Moreover, with the integration of cutting-edge technologies in hospitals, physicians are equipped with tools that provide accurate and efficient biopsy outcomes. The focus on improving patient care and reducing hospital stays is also propelling the adoption of minimally invasive biopsy procedures, thereby positively impacting the market.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) have emerged as significant contributors to the biopsy forceps, polypectomy snares, and EUS needles market due to the rising trend of outpatient surgeries. The demand for minimally invasive procedures performed in ASCs is growing as patients prefer quicker recovery times and reduced healthcare costs. These centers are equipped with advanced technologies that facilitate various diagnostic and therapeutic procedures, increasing the utilization of biopsy instruments. Furthermore, ASCs provide a comfortable and efficient setting for patients, enhancing the overall patient experience. The ongoing expansion of ASCs and the increasing number of procedures performed in these facilities are driving the market for these medical instruments.

Specialty Clinics:

Specialty clinics are increasingly utilizing biopsy forceps and related instruments for targeted diagnostics in specific medical fields, such as gastroenterology and oncology. These clinics often focus on particular types of diseases, allowing for a higher volume of specialized procedures. The demand for advanced diagnostic tools in specialty clinics is growing as they aim to provide precise and effective treatments to patients. The collaboration between specialty clinics and hospitals to streamline patient referrals for biopsy procedures is also contributing to the market expansion. Moreover, the emphasis on personalized medicine and tailored treatment plans is driving the need for accurate biopsy sampling in these settings.

Diagnostic Centers:

Diagnostic centers play a crucial role in the biopsy forceps, polypectomy snares, and EUS needles market, as they are pivotal in the early detection of diseases. These centers are equipped with advanced imaging and diagnostic tools that facilitate accurate sampling for pathology evaluation. The increasing demand for precise diagnostic procedures is driving the need for high-quality biopsy instruments in these facilities. Additionally, the rise in preventive healthcare measures and early screening programs is leading to a greater number of biopsies being performed, further augmenting the market. Diagnostic centers are continuously adopting innovative technologies to enhance the quality of care provided to patients, making them an essential segment of the market.

By End User

Gastroenterology Centers:

Gastroenterology centers are significant consumers of biopsy forceps and related instruments, given their specialized focus on gastrointestinal diseases. The increasing prevalence of disorders such as inflammatory bowel disease, colorectal cancer, and liver diseases has resulted in a heightened demand for effective diagnostic tools in these settings. Gastroenterologists rely on advanced biopsy techniques to obtain accurate samples for pathology assessments, thereby aiding in the early diagnosis and treatment of various conditions. The integration of advanced imaging technologies in gastroenterology practices is also driving the need for specialized biopsy instruments, as these tools enhance the efficiency and precision of procedures. The growing emphasis on preventive care in gastroenterology is further propelling the market for biopsy forceps.

Oncology Centers:

Oncology centers are a vital end-user segment for biopsy forceps and related products, as they focus on the diagnosis and treatment of cancer. The rising incidence of various cancers globally is driving the demand for accurate and efficient biopsy procedures in these centers. Oncology specialists often utilize advanced biopsy techniques to obtain tissue samples for histopathological analysis, which is crucial for determining appropriate treatment plans. The increasing adoption of minimally invasive techniques in oncology is contributing to the growing demand for specialized biopsy instruments. Moreover, ongoing research and clinical trials in oncology are emphasizing the need for innovative biopsy tools that can provide precise results, further driving the market in this segment.

Hospitals:

Hospitals represent a significant end-user segment for biopsy forceps and related instruments, as they offer a wide array of diagnostic and therapeutic services. Due to the increasing number of patients presenting with gastrointestinal disorders and cancers, hospitals are witnessing a surge in the demand for biopsy procedures. The integration of advanced technologies in hospitals enhances the efficacy of biopsy techniques, leading to improved patient outcomes. Additionally, the focus on patient safety and infection control has prompted hospitals to adopt high-quality biopsy instruments that offer precision and reliability. The continuous expansion of hospital facilities and services is expected to bolster the market for biopsy forceps and related products in the coming years.

By Shaft Type

Flexible Shaft Biopsy Forceps:

Flexible shaft biopsy forceps are designed to navigate the complex anatomy of the gastrointestinal tract, allowing for effective sampling of tissue from challenging locations. Their flexibility is a critical advantage, as it enables healthcare professionals to access various angles and positions during endoscopic procedures. The growing preference for flexible instruments in minimally invasive surgeries is driving the demand for flexible shaft biopsy forceps. These instruments provide enhanced maneuverability and precision, resulting in higher-quality biopsy samples. The continuous innovation in the design and materials used for flexible shaft biopsy forceps is improving their performance, further boosting their adoption across healthcare settings.

Rigid Shaft Biopsy Forceps:

Rigid shaft biopsy forceps offer a stable and strong design ideal for obtaining tissue samples from less accessible areas. They are particularly useful in applications where precision and stability are paramount. The increasing demand for diagnostic accuracy and the need for reliable sampling techniques in endoscopic procedures are contributing to the market growth for rigid shaft biopsy forceps. These instruments are often preferred in surgical settings where a firm grip and control are required during the biopsy process. The ongoing advancements in the manufacturing of rigid shaft biopsy forceps, including ergonomic designs and improved materials, are anticipated to enhance their market presence and usability.

By Size

Small Biopsy Forceps:

Small biopsy forceps are designed for delicate procedures where precision is crucial. These instruments are particularly beneficial for sampling from small or densely packed lesions, ensuring minimal damage to surrounding tissues. The increasing focus on minimally invasive techniques in various medical fields is driving the demand for small biopsy forceps. Their compact design allows for easy maneuverability, making them ideal for procedures where access is limited. As healthcare professionals continue to prioritize patient safety and effective diagnostic sampling, the market for small biopsy forceps is expected to grow significantly in the coming years.

Medium Biopsy Forceps:

Medium biopsy forceps strike a balance between size and functionality, making them versatile tools in various diagnostic and therapeutic applications. These instruments are commonly used in routine procedures and are suitable for a wide range of tissue types. The demand for medium biopsy forceps is driven by their adaptability, as they can be employed in both flexible and rigid shaft applications. The continued focus on enhancing diagnostic accuracy and efficiency in medical procedures supports the market growth for medium-sized biopsy forceps. As the healthcare sector evolves, the versatility offered by medium biopsy forceps will likely contribute to their sustained usage across clinical settings.

Large Biopsy Forceps:

Large biopsy forceps are specifically designed for obtaining samples from larger lesions or masses. Their robust construction allows for the collection of substantial tissue samples, which is essential for accurate diagnosis, particularly in oncology. The growing incidence of tumor-related conditions is driving the demand for large biopsy forceps, as healthcare providers seek to ensure comprehensive sampling for pathological evaluation. The ongoing advancements in the design and material quality of large biopsy forceps are enhancing their performance and efficiency in tissue sampling. As an integral part of oncology and gastrointestinal procedures, large biopsy forceps are expected to maintain a significant presence in the market.

By Region

In North America, the biopsy forceps, polypectomy snares, and EUS needles market is projected to dominate due to the well-established healthcare infrastructure and high adoption of advanced medical technologies. The increasing prevalence of gastrointestinal diseases and cancers in the region is driving demand for these specialized instruments, with the market size estimated to reach approximately USD 600 million by 2033. The CAGR in North America is expected to be around 8% during the forecast period, reflecting the region's commitment to providing high-quality healthcare services and innovative medical solutions. On the other hand, the Europe market is also anticipated to experience substantial growth, supported by increasing healthcare expenditure and the rising number of endoscopic procedures being performed across the region.

In the Asia Pacific region, rapid economic growth, coupled with improvements in healthcare infrastructure, is expected to fuel the demand for biopsy forceps, polypectomy snares, and EUS needles. The market in Asia Pacific is projected to reach USD 400 million by 2033, with a CAGR of approximately 9% during the forecast period. The rising awareness of early disease detection and preventive healthcare measures is driving investments in advanced medical technologies within this region. Additionally, the growing geriatric population is contributing to the increased prevalence of gastrointestinal disorders, further propelling the market forward. Latin America and the Middle East & Africa are also expected to witness growth, although at a slower pace due to varying levels of healthcare access and infrastructure development.

Opportunities

The Biopsy Forceps, Polypectomy Snares, and EUS Needles market presents numerous opportunities for healthcare providers and manufacturers alike. One of the most significant opportunities lies in the continuous evolution of technology within the medical field. Innovations such as robotic-assisted biopsy instruments and advanced imaging techniques are opening new frontiers for improved diagnostic accuracy and patient outcomes. By investing in research and development, companies can create state-of-the-art biopsy instruments that cater to emerging medical needs and preferences, thereby positioning themselves as leaders in this competitive market. Furthermore, there is a growing emphasis on personalized medicine, which demands precise tissue sampling for tailored treatment plans. This provides an avenue for manufacturers to develop specialized biopsy instruments that facilitate targeted diagnostics, further enhancing market potential.

Additionally, the global shift towards value-based healthcare is creating an opportunity for the biopsy forceps and polypectomy snares market. As healthcare systems increasingly prioritize patient outcomes and cost-effectiveness, there is a greater demand for high-quality biopsy instruments that can deliver reliable results while minimizing complications and hospital stays. Companies that can demonstrate the effectiveness and efficiency of their products in improving patient care will likely gain favor among healthcare providers and institutions. Moreover, emerging markets in Asia Pacific and Latin America present substantial growth opportunities for industry players. By expanding their reach into these regions and establishing partnerships with local healthcare providers, manufacturers can capitalize on the rising demand for advanced diagnostic tools in these burgeoning markets.

Threats

Despite the promising growth trajectory of the Biopsy Forceps, Polypectomy Snares, and EUS Needles market, several threats could hinder its expansion. One of the foremost challenges is the increasing competition among manufacturers, resulting in price wars and reduced profit margins. As more players enter the market, there is a risk of oversupply, which can lead to decreased prices and profitability for established companies. Additionally, the rapid pace of technological advancements requires continuous innovation, and manufacturers may struggle to keep up with the evolving landscape. Failure to adapt to new technologies or address changing market demands can result in lost market share and diminished competitiveness. Furthermore, regulatory hurdles and approval processes for new medical devices can delay product launches, impacting revenue generation for companies.

Another significant threat to the market is the potential for product recalls and quality control issues. Any incidents related to the safety or efficacy of biopsy instruments can lead to substantial reputational damage for manufacturers, affecting customer trust and sales. Additionally, the rising concern for patient safety and the growing trend of patient preferences towards non-invasive diagnostic options could shift demand away from traditional biopsy procedures. The increasing popularity of alternative diagnostic methods, such as liquid biopsies, presents a challenge to the established market players, necessitating adaptation and innovation to stay relevant.

Competitor Outlook

• Boston Scientific Corporation
• Medtronic PLC
• Cook Medical
• Johnson & Johnson
• Stryker Corporation
• ConMed Corporation
• Olympus Corporation
• Hologic, Inc.
• EndoChoice, Inc.
• Smith & Nephew PLC
• PENTAX Medical Company
• Terumo Corporation
• Medline Industries, Inc.
• Argon Medical Devices, Inc.
• Intuitive Surgical, Inc.

The competitive landscape of the Biopsy Forceps, Polypectomy Snares, and EUS Needles market is characterized by the presence of numerous established players and emerging companies striving to innovate and capture market share. Major companies such as Boston Scientific Corporation and Medtronic PLC have a strong foothold in the market due to their extensive portfolios of advanced biopsy and endoscopic instruments. These companies continually invest in research and development to introduce cutting-edge products that meet the diverse needs of healthcare providers. Additionally, their established distribution networks and strong brand recognition enhance their competitive advantage, allowing them to maintain a significant market presence.

Cook Medical and Johnson & Johnson are also key players in this market, known for their wide range of biopsy forceps and related products. These companies leverage their extensive experience and expertise to develop reliable and high-quality instruments that cater to various clinical applications. Their commitment to innovation and quality assurance helps them maintain a loyal customer base and drive repeat business. Furthermore, companies like Stryker Corporation and ConMed Corporation focus on expanding their product offerings and enhancing their technological capabilities to stay competitive in the evolving market landscape.

Emerging players such as Hologic, Inc. and EndoChoice, Inc. are making significant strides in the market by offering specialized biopsy instruments that cater to specific medical needs. These companies often target niche segments and leverage innovative technologies to differentiate themselves from established competitors. As the market continues to evolve, the competitive dynamics will likely shift, with companies continually striving to enhance their product offerings and capitalize on new opportunities within the biopsy and polypectomy segment.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Cook Medical
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Hologic, Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic PLC
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 EndoChoice, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Johnson & Johnson
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 ConMed Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Smith & Nephew PLC
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Terumo Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Olympus Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Stryker Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 PENTAX Medical Company
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Intuitive Surgical, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Medline Industries, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Argon Medical Devices, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Boston Scientific Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Biopsy Forceps Polypectomy Snares and EUS Needles Market, By Size
    • 6.1.1 Small Polypectomy Snares
    • 6.1.2 Medium Polypectomy Snares
    • 6.1.3 Large Polypectomy Snares
  • 6.2 Biopsy Forceps Polypectomy Snares and EUS Needles Market, By End User
    • 6.2.1 Gastroenterology Centers
    • 6.2.2 Oncology Centers
    • 6.2.3 Hospitals
  • 6.3 Biopsy Forceps Polypectomy Snares and EUS Needles Market, By Shaft Type
    • 6.3.1 Flexible Shaft Biopsy Forceps
    • 6.3.2 Rigid Shaft Biopsy Forceps
  • 6.4 Biopsy Forceps Polypectomy Snares and EUS Needles Market, By Application
    • 6.4.1 Hospitals
    • 6.4.2 Ambulatory Surgical Centers
    • 6.4.3 Specialty Clinics
    • 6.4.4 Diagnostic Centers
  • 6.5 Biopsy Forceps Polypectomy Snares and EUS Needles Market, By Product Type
    • 6.5.1 Hot Polypectomy Snares
    • 6.5.2 Cold Polypectomy Snares
    • 6.5.3 Injection Polypectomy Snares

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Biopsy Forceps Polypectomy Snares and EUS Needles Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Biopsy Forceps Polypectomy Snares and EUS Needles market is categorized based on

By Product Type

• Hot Polypectomy Snares
• Cold Polypectomy Snares
• Injection Polypectomy Snares

By Application

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Diagnostic Centers

By End User

• Gastroenterology Centers
• Oncology Centers
• Hospitals

By Shaft Type

• Flexible Shaft Biopsy Forceps
• Rigid Shaft Biopsy Forceps

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

By Size

• Small Polypectomy Snares
• Medium Polypectomy Snares
• Large Polypectomy Snares

Key Players

• Boston Scientific Corporation
• Medtronic PLC
• Cook Medical
• Johnson & Johnson
• Stryker Corporation
• ConMed Corporation
• Olympus Corporation
• Hologic, Inc.
• EndoChoice, Inc.
• Smith & Nephew PLC
• PENTAX Medical Company
• Terumo Corporation
• Medline Industries, Inc.
• Argon Medical Devices, Inc.
• Intuitive Surgical, Inc.